Sort
21,453 grants matching “tuberculosis”
Center to develop therapeutic countermeasures to high-threat bacterial agents
$5,504,272David S Perlin · Rbhs-New Jersey Medical School · U19 · FY2016 · AI
Infectious Disease Genomics: Pathogen Evolution, Emergence, and Host Interaction
$5,496,338Bruce W. Birren · Broad Institute, Inc. · U19 · FY2018 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$5,493,765Jeffrey Lennox · Emory University · UM1 · FY2019 · AI
Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis
$5,490,179Kathlenn Kozar · Tulane University · N01 · FY2013 · AI
Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb.
$5,485,460Nader Fotouhi · Global Alliance For Tb Drug Development · U19 · FY2019 · AI
Vaccine and Treatment Evaluation Units
$5,485,363Nadine Georges Rouphael · Emory University · UM1 · FY2020 · AI
Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb.
$5,472,466Nader Fotouhi · Global Alliance For Tb Drug Development · U19 · FY2023 · AI
Studies of Medical Radiation and Other Therapeutic Agents
$5,452,871Amy Berrington · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Infectious Disease Genomics: Pathogen Evolution, Emergence, and Host Interaction
$5,445,286Bruce W. Birren · Broad Institute, Inc. · U19 · FY2014 · AI
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)
$5,443,065Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2024 · AI
SDMC: HIV Vaccine Trials Network
$5,436,127Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI
Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center (RICC) (RePORT RICC)
$5,400,000Michael Dignam · National Institute Of Allergy And Infectious Diseases · Y01 · FY2020 · AI
Center to develop therapeutic countermeasures to high-threat bacterial agents
$5,399,115David S Perlin · Rbhs-New Jersey Medical School · U19 · FY2014 · AI
COOPERATIVE AGREEMENT WITH THE KENYA MEDICAL RESEARCH INSTITUTE (KEMRI)
$5,347,112John Vulule · Kenya Medical Research Institute (Kemri) · U19 · FY2013 · GH
Southwest National Primate Research Center
$5,329,661Southwest Foundation For Biomedical Res · P51 · FY2005 · RR
STRUCTURAL ORGANIZATION AND PROTEOMICS OF TB
$5,274,660University Of Calif-Los Alamos Nat Lab · P50 · FY2001 · GM
Center to develop therapeutic countermeasures to high-threat bacterial agents
$5,254,272David S Perlin · Rbhs-New Jersey Medical School · U19 · FY2015 · AI
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$5,246,488Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2020 · AI
Simian Vaccine Evaluation Unit (SVEU)
$5,229,662Phillip D Markham · Advanced Bioscience Laboratories, Inc. · N01 · FY2010 · AI
Laboratory for Combinatorial Drug Regimen Design for Resistant and Emerging Pathogens
$5,147,109Linden T Hu · Tufts University Boston · C06 · FY2022 · OD
CoVPN - COVID Countermeasures
$5,088,428Ann R Falsey · University Of Rochester · UM1 · FY2020 · AI
Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis
$5,082,137Jay Evans · Corixa Corporation · N01 · FY2014 · AI
IMPACTA PERU CLINICAL TRIALS UNIT
$5,080,925Javier R Lama · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2019 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$5,079,101Joseph Burzynski · New York City Health/Mental Hygiene · U52 · FY2014 · PS
Infectious Disease Genomics: Pathogen Evolution, Emergence, and Host Interaction
$5,063,540Bruce W. Birren · Broad Institute, Inc. · U19 · FY2017 · AI